Respin 11

The need for airway clearance is not disease-specific, but may arise from a variety of risk factors that impair normal secretion clearance:

  • Recurrent respiratory infections
  • Respiratory muscle weakness
  • Mucus plugging and atelectasis
  • Increased difficulty in breathing
  • Hyper production of secretions
  • More frequent tightness in the chest
  • Abnormally thick, sticky secretions
  • Ineffective cough

RespIn 11 benefits from a totally new innovative approach to the 30-year-old concept of High Frequency Chest Wall Oscillation/Chest Compression therapy.

‘Focused pulse’ used in Respin 11* transfers only 10% of the energy to the patient that High Frequency Chest Compression devices or HFCWO therapy devices do.

This means for the patient that they only need to be able to tolerate 1/10th of the energy that existing devices on the market today deliver.

  • Therapeutic pulsations directly to targeted areas
  • Independent treatment areas
  • No negative physiological side effects
  • Creates 4-5 times greater lungs movement
  • Very low background pressure
  • Improved therapy compliance
  • Wide range of patients and ages.

The RespIn 11 uses an innovative patented system of ‘focused pulse’ technology incorporating a system of proprietary valves, pressure pistons and electronic controls which deliver therapeutic pulsations directly to targeted areas of the patient’s thorax - exactly where most required and most beneficial in the treating clinician’s view.

  • 4 preset protocols
  • Can store up to 3 Customer therapies
  • Pads and wraps size range
  • Pads for bedridden patients
  • Easy to use
  • User-friendly display.

* temporarily not available in Russia